ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.
In March 2021, an affiliate of our sponsor paid $25,000, or approximately $0.004 per share, to cover certain of our offering costs, in exchange for an aggregate of 5,750,000 founder shares, which were subsequently transferred to our sponsor.
Our sponsor committed, pursuant to a written agreement, to purchase an aggregate of 4,666,667 private placement warrants (or 5,066,667 warrants if the underwriters’ over-allotment option is exercised in full), each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per whole warrant, or $7,000,000 in the aggregate (or $7,600,000 if the underwriters’ over-allotment option is exercised in full), in a private placement that occurred concurrently with the closing of the IPO. On November 30, 2021, the underwriters purchased an additional 1,240,488 Option Units pursuant to the partial exercise of the Over-Allotment Option. The Option Units were sold at an offering price of $10.00 per Unit, generating aggregate additional gross proceeds of $12,404,880 to the Company.
On November 30, 2021, in connection with the underwriter’s partial exercise of the over-allotment option, our sponsor surrendered 439,878 founder shares. Also in connection with the partial exercise of the Over-Allotment Option, the Sponsor purchased an additional 165,398 warrants at a purchase price of $1.50 per whole warrant. The private placement warrants are identical to the warrants sold in the IPO except that the private placement warrants, so long as they are held by our sponsor or its permitted transferees, (i) will not be redeemable by us, (ii) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of our initial business combination, (iii) may be exercised by the holders on a cashless basis and (iv) are entitled to registration rights. The private placement warrants may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder. If we do not complete our initial business combination by October 19, 2023, the private placement warrants will expire worthless. The private placement warrants are subject to the transfer restrictions described below.
Certain institutions, who we refer to as “sponsor members” throughout this Annual Report, are members in, but are not affiliates of our sponsor. Such “sponsor members” are (i) certain funds and accounts managed by or affiliated with Sea Otter Securities Group LLC, Sculptor Capital LP, Meteora Capital LLC, Magnetar Financial LLC, Greytail Cove I LLC, Major Tom Private Capital LLC, Atalaya Capital Management LP and Corbin Capital Partners, L.P., Radcliffe Capital Management, L.P., Basso SPAC Fund LLC and Citadel Advisors, each of which indicated an interest in purchasing units sold in our Initial Public Offering and is a member in our sponsor and has an indirect beneficial interest in up to 150,000 founder shares (and one of whom, in addition, has an indirect beneficial interest in 186,666 private placement warrants); and (ii) two investors that expressed an interest to purchase up to 4.9% of the units sold in the Initial Public Offering (excluding the units sold when the underwriters partially exercised the over-allotment option) and each is a member in our sponsor and has an indirect beneficial interest in up to 75,000 founder shares. None of those funds or accounts is a managing member of our sponsor, nor do they have any management authority with respect to our sponsor. Unlike the other participants in the sponsor, the sponsor members are not subject to any lockup restriction on the transfer of their ordinary shares and are not subject to forfeiture or adjustment with respect to their founder shares received in connection with their purchase of units in the Initial Public Offering, and while they generally agree or will use reasonable best efforts to vote their ordinary shares in favor of the business combination, this voting commitment only applies to ordinary shares still held by them. Further, with respect to units purchased in the Initial Public Offering, the sponsor members have the same rights (including redemption rights) as other public purchasers of units.
We currently utilize office space at 3626 N Hall St, Suite 910, Dallas, Texas 75219, from our sponsor as our executive offices. Commencing on October 19, 2021, we may pay our sponsor or an affiliate thereof up to $10,000 per month for office space, utilities, salaries or other cash compensation paid to consultants to our sponsor, secretarial and administrative support services provided to members of our management team and other expenses and obligations of our sponsor. Upon completion of our initial business combination or our liquidation, we will cease paying these monthly fees.
No compensation of any kind, including finder’s and consulting fees, will be paid by the company to our sponsor, officers and directors, or any of their respective affiliates, for services rendered prior to or in connection with the completion of an initial business combination. In addition, these individuals will be reimbursed for any
expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made by us to our sponsor, officers, directors or our or their affiliates.
In order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required on a
non-interest
basis. If we complete an initial business combination, we would repay such loaned amounts. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into private placement warrants of the post business combination entity at a price of $1.50 per whole warrant at the option of the lender at the time of the business combination. Such warrants would be identical to the private placement warrants. Except as set forth